# Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?

> **NCT01699230** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 30 (estimated)

## Conditions studied

- Coronary Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Omega 3

## Key facts

- **NCT ID:** NCT01699230
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699230, "Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01699230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*